Genstar Capital Makes Majority Investment in Flourish Research
September 19, 2024
September 19, 2024
BOSTON, Massachusetts, Sept. 19 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Genstar Capital in its majority investment in Flourish Research, an NMS Capital portfolio company and leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.
The announcement was made in a Sept. 18 press release. Terms of the transaction were not disclosed.
. . .
Ropes & Gray represented Genstar Capital in its majority investment in Flourish Research, an NMS Capital portfolio company and leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.
The announcement was made in a Sept. 18 press release. Terms of the transaction were not disclosed.
. . .